Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3067% below fair value
$171.41−17.78 (-9.40%)
Close on Nov 12, 2026Market cap $1.17BP/E 7.3Yield –
Nutex Health gross margin
Gross margin is gross profit as a percentage of revenue.
Nutex Health's gross margin for the twelve months ending Sep 30, 2026 was 47.8%. For fiscal 2025 it was 50.8%, against 40.9% the year before. The highest annual figure on record is 98.3% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 50.8% | +9.9 |
| FY2024 | Dec 31, 2024 | 40.9% | +26.9 |
| FY2023 | Dec 31, 2023 | 14.0% | +7.0 |
| FY2022 | Dec 31, 2022 | 7.0% | −47.0 |
| FY2021 | Dec 31, 2021 | 54.1% | −3.4 |
| FY2020 | Dec 31, 2020 | 57.5% | +18.3 |
| FY2019 | Dec 31, 2019 | 39.2% | −23.6 |
| FY2018 | Dec 31, 2018 | 62.9% | +94.4 |
| FY2017 | Dec 31, 2017 | -31.6% | −129.9 |
| FY2015 | Dec 31, 2015 | 98.3% | +41.8 |
| FY2014 | Dec 31, 2014 | 56.5% | −9.6 |
| FY2013 | Dec 31, 2013 | 66.1% | +15.2 |
| FY2012 | Dec 31, 2012 | 50.8% | −6.3 |
| FY2011 | Dec 31, 2011 | 57.1% | +1.9 |
| FY2010 | Dec 31, 2010 | 55.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 46.7% | −11.2 |
| Q2 FY2026 | Jun 30, 2026 | 67.0% | +15.8 |
| Q1 FY2026 | Mar 31, 2026 | 42.4% | −13.5 |
| Q4 FY2025 | Dec 31, 2025 | 30.4% | −24.6 |
| Q3 FY2025 | Sep 30, 2025 | 57.8% | +30.0 |
| Q2 FY2025 | Jun 30, 2025 | 51.2% | +21.5 |
| Q1 FY2025 | Mar 31, 2025 | 55.9% | +40.8 |
| Q4 FY2024 | Dec 31, 2024 | 55.0% | +36.0 |
| Q3 FY2024 | Sep 30, 2024 | 27.8% | +16.5 |
| Q2 FY2024 | Jun 30, 2024 | 29.7% | +13.3 |
| Q1 FY2024 | Mar 31, 2024 | 15.1% | +6.5 |
| Q4 FY2023 | Dec 31, 2023 | 19.0% | +18.0 |
| Q3 FY2023 | Sep 30, 2023 | 11.3% | +94.8 |
| Q2 FY2023 | Jun 30, 2023 | 16.4% | +4.9 |
| Q1 FY2023 | Mar 31, 2023 | 8.6% | −36.7 |
| Q4 FY2022 | Dec 31, 2022 | 1.0% | −29.7 |
| Q3 FY2022 | Sep 30, 2022 | -83.5% | −147.9 |
| Q2 FY2022 | Jun 30, 2022 | 11.4% | −35.0 |
| Q1 FY2022 | Mar 31, 2022 | 45.3% | +24.1 |
| Q4 FY2021 | Dec 31, 2021 | 30.7% | −26.8 |
| Q3 FY2021 | Sep 30, 2021 | 64.4% | +24.7 |
| Q2 FY2021 | Jun 30, 2021 | 46.4% | +16.3 |
| Q1 FY2021 | Mar 31, 2021 | 21.2% | −36.0 |
| Q4 FY2020 | Dec 31, 2020 | 57.6% | +6.5 |
| Q3 FY2020 | Sep 30, 2020 | 39.8% | −17.4 |
| Q2 FY2020 | Jun 30, 2020 | 30.0% | +3.5 |
| Q1 FY2020 | Mar 31, 2020 | 57.2% | +36.6 |
| Q4 FY2019 | Dec 31, 2019 | 51.1% | −12.7 |
| Q3 FY2019 | Sep 30, 2019 | 57.2% | −8.1 |
| Q2 FY2019 | Jun 30, 2019 | 26.6% | +138.4 |
| Q1 FY2019 | Mar 31, 2019 | 20.6% | +109.8 |
| Q4 FY2018 | Dec 31, 2018 | 63.8% | +277.9 |
| Q3 FY2018 | Sep 30, 2018 | 65.3% | −30.6 |
| Q2 FY2018 | Jun 30, 2018 | -111.9% | – |
| Q1 FY2018 | Mar 31, 2018 | -89.2% | – |
| Q2 FY2017 | Jun 30, 2017 | -214.1% | – |
| Q1 FY2017 | Mar 31, 2017 | 95.9% | – |
See a number that looks wrong?